Copiktra Interactions
There are 602 drugs known to interact with Copiktra (duvelisib), along with 4 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 159 are major, 390 are moderate, and 53 are minor.
- View all 602 medications that may interact with Copiktra
- View Copiktra alcohol/food interactions (1)
- View Copiktra disease interactions (4)
Most frequently checked interactions
View interaction reports for Copiktra (duvelisib) and the medicines listed below.
- acetaminophen
- Adriamycin RDF (doxorubicin)
- Advate (antihemophilic factor)
- Adzenys XR-ODT (amphetamine)
- Aleve (naproxen)
- Alimta (pemetrexed)
- alpha-lipoic acid
- Alphanate (antihemophilic factor/von willebrand factor)
- alprazolam
- amlodipine / hydrochlorothiazide / olmesartan
- Aptiom (eslicarbazepine)
- Ativan (lorazepam)
- baclofen
- Bactrim DS (sulfamethoxazole / trimethoprim)
- Baraclude (entecavir)
- Baxdela (delafloxacin)
- Benadryl (diphenhydramine)
- Butrans (buprenorphine)
- cannabis
- Capastat (capreomycin)
- Celestone Soluspan (betamethasone)
- chlorpheniramine
- cholecalciferol
- cimetidine
- Cipro I.V. (ciprofloxacin)
- clindamycin
- Cotempla XR-ODT (methylphenidate)
- Coumadin (warfarin)
- Creon (pancrelipase)
- Tegretol (carbamazepine)
Copiktra alcohol/food interactions
There is 1 alcohol/food interaction with Copiktra (duvelisib).
Copiktra disease interactions
There are 4 disease interactions with Copiktra (duvelisib) which include:
More about Copiktra (duvelisib)
- Copiktra consumer information
- Compare alternatives
- Drug images
- Latest FDA alerts (1)
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: PI3K inhibitors
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.